Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

1391 - 1400 of 3627 results found

Heparinas de bajo peso molecular versus clásicas en enfermedad tromboembólica (Informe nº: Osteba D-02-08)

MeSH Terms
Embolism and Thrombosis (C14.907.355); Heparin; Low-Molecular-Weight (D09.698.373.400.300); Heparin (D09.698.373.400); Anticoagulants (D27.505.954.502.119); Meta-Analysis (V03.600); Patient Safety (N06.850.135.060.075.399); Efficiency (F02.784.692.351)
Guideline Contact
Asun Gutiérrez Iglesias ([email protected])
English Title Translation
Low molecular weight heparins versus traditional heparins in thromboembolic diseases
Publication Scope
management
treatment
Countries of Application
Spain
Guideline Publication Status
Published
Languages
Spanish
Authors
OSTEBA (ES)
Publication Year
2003

Hepatic Arterial Infusion for Colorectal Liver Metastases

MeSH Terms
colorectal neoplasms, colorectal tumor, colorectal, colon, colonic, rectal, rectum, rectosigmoid, cancer, neoplasm, adenocarcinoma, malignancy, tumour, carcinoma, liver, hepatic artery infusion, hepatic, metastases, metastatic, metastasis
Guideline Contact
Roxanne Cosby; [email protected]
Keywords
colorectal neoplasms, colorectal tumor, rectum, liver, hepatic artery infusion, hepatic
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
2021-05-28
Date of Last Evidence Search
2021-03-17
Methods Applied
Evidence-based, Systematic review-based, Externally reviewed, Evidence quality assessment
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2021

Hepatic, Pancreatic and Biliary Tract Surgical Oncology Standards

MeSH Terms

Liver Neoplasms (C04.588.274.623); Hepatectomy (E04.210.556); Pancreatic Neoplasms (C04.588.274.761); Pancreatectomy (E04.210.752); Biliary Tract Diseases (C06.130); Cholecystectomy (E04.210.120.172)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2015

Hepatitis B and C testing: people at risk of infection (PH43)

MeSH Terms
Digestive System Diseases (C06); Preventive Health Services (N02.421.726); Public Health (N06.850); Liver Diseases (C06.552); Primary Prevention (N02.421.726.758); Public Health Practice (N06.850.780); Hepatitis (C06.552.380); Mass Screening (E01.370.500)
Publication Scope
prevention
Countries of Application
United Kingdom
Guideline Publication Status
Published
Languages
English
Authors
NICE (UK)
Publication Year
2012

Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy: ASCO PCO Update

MeSH Terms
Hepatitis (C06.552.380); Neoplasms (C04); Antineoplastic Agents (D27.505.954.248)
Guideline Contact
[email protected]
Publication Date
27-Jul-20
Date of Last Evidence Search
20-Jan
Publication Scope
management
screening
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2020

Hepatocellulair carcinoom

MeSH Terms
Carcinoma; Hepatocellular (C04.557.470.200.025.255)
Guideline Contact
Mirte Tilma ([email protected])
English Title Translation
Hepatocellular carcinoma
Publication Scope
assessment
management
patient_education
prevention
prognosis
rehabilitation
screening
Countries of Application
Netherlands
Guideline Publication Status
Published
Languages
Dutch
Authors
IKNL (NL)
Publication Year
2013

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), and American Society of Clinical Oncology (ASCO)

MeSH Terms

Histological Techniques (E05.200.750); Standard of Care (N05.715.840); Quality Assurance; Health Care (N05.700); Quality of Health Care (N05.715); Antibodies; Monoclonal; Humanized (D12.776.124.486.485.114.224.060); Gastrointestinal Tract (A03.556); Adenocarcinoma (C04.557.470.200.025); Gastrointestinal Neoplasms (C04.588.274.476); Stomach Neoplasms (C04.588.274.476.767); Molecular Diagnostic Techniques (E05.200.880)

Guideline Contact
Tanja Kalicanin ([email protected])
Keywords
her2, gastric, human epidermal growth factor receptor 2, clinical guideline, gastroesophageal, gea, cancer
Publication Date
Original: November 14, 2016
Expected Publication Date
Update: Q4, 2025
Publication Scope
assessment
treatment
Countries of Application
United States
Guideline Publication Status
Development
Languages
English
Authors
CAP (US)
Publication Year
2016

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

MeSH Terms
Neoplasms (C04); Gastrointestinal Neoplasms (C04.588.274.476)
Guideline Contact
[email protected]
Publication Date
14-Nov-16
Publication Scope
assessment
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2016

Hereditair mamma/ovariumcarcinoom. National consensus-based guideline

MeSH Terms
Cancer / Neoplasms (C04); Breast Neoplasms (C04.588.180); Endocrine Gland Neoplasms (C04.588.322); Urogenital Neoplasms (C04.588.945); Ovarian Neoplasms (C04.588.322.455); Ovarian Neoplasms (C13.371.270.750)
English Title Translation
Hereditary breast cancer and ovarian cancer
Publication Scope
assessment
management
Countries of Application
Netherlands
Guideline Publication Status
Published
Languages
Dutch
Authors
IKNL (NL)
Publication Year
2010